• patients
  • Antimalarial treatment is shown to be effective in decreasing splenomegaly, correcting anemia and lymphocytosis, and decreasing serum IgM in patients with HMS. (medscape.com)
  • The aim of this study is to document and compare the benefits of LS, HALS, and OS in patients with splenomegaly. (sages.org)
  • cause
  • Congenital conditions associated with hemolysis and increased red blood cell turnover that cause splenomegaly include: hereditary spherocytosis and hemoglobinopathies, especially alpha and beta thalassemias and sickle cell-hemoglobin C (or hemoglobin SC disease). (oncologynurseadvisor.com)
  • ascites
  • Past history in a group of 159 individuals with schistosomal splenomegaly revealed hematemesis in 12.6 percent and ascites, edema and/or jaundice in 1.9 percent. (ajtmh.org)